Whitney Shatz-Binder, PhD
Senior Principal Scientist
Bio:
Dr Whitney Shatz-Binder is a Senior Principal Scientist in Pharmaceutical Development at Genentech, where she leads strategic initiatives to advance innovative drug delivery platforms. With over 20 years of experience in the biopharmaceutical industry, her work focuses on the development and industrialization of advanced therapeutic modalities to address complex diseases across ophthalmology, oncology, immunology and neurodegeneration.
Since joining Genentech in 2007, Dr Shatz-Binder has been a driving force in bridging discovery research with clinical translation, pioneering efforts in protein-conjugates, long-acting delivery strategies, and targeted lipid nanoparticles (tLNPs) for nucleic acid-based medicines.
Academically, she holds a PhD from the University of Geneva, where she pioneered the use of ferritin cages for drug delivery, and BS/MS degrees in Biochemistry and Molecular Biology from UC Santa Barbara. A prolific contributor to the field, she has authored over 40 peer-reviewed publications and is a co-inventor on multiple issued patents.